• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Veramark Technologies

Veramark Technologies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Therapeutics Pipeline Report H1 2017 - Review of 14 Companies & Drug Profiles Including Celgene, Merck & Pfizer - Research and Markets

    Global Post-Polycythemia Vera Myelofibrosis (PPV-MF) Therapeutics Pipeline Report H1 2017 - Review of 14 Companies & Drug Profiles Including Celgene, Merck & Pfizer - Research and Markets

  2. Company Profile for MuleSoft

    Company Profile for MuleSoft

  3. Top Leaders in Beauty and Retail Honored at the 2017 Outstanding Mother Awards

    Top Leaders in Beauty and Retail Honored at the 2017 Outstanding Mother Awards

  4. Wellbeing Beauty Brand, Philosophy and Its Hope & Grace Initiative, Kick off Mental Health Month with “How Are You, Really?” PSA and National Campaign

    Wellbeing Beauty Brand, Philosophy and Its Hope & Grace Initiative, Kick off Mental Health Month with “How Are You, Really?” PSA and National Campaign

  5. Our Outlook for Consumer Cyclical Stocks

    As macro headwinds mount, we would look for a larger valuation discount among consumer cyclical names.

  6. Our Outlook for the Market

    As the risk of increasing inflation looms, the risk/reward opportunity in stocks does not signal a screaming buy to us at this point.

  7. Our Outlook for Consumer Cyclical Stocks

    The U.S. economy is in decent shape, but we are being even more selective given recent outperformance.

©2017 Morningstar Advisor. All right reserved.